165 related articles for article (PubMed ID: 7695232)
41. Distribution of preproenkephalin, preprotachykinin A, and preprodynorphin mRNAs in the rat nucleus accumbens: effect of repeated administration of nicotine.
Mathieu AM; Caboche J; Besson MJ
Synapse; 1996 Jun; 23(2):94-106. PubMed ID: 8723714
[TBL] [Abstract][Full Text] [Related]
42. Evidence for a preferential loss of enkephalin immunoreactivity in the external globus pallidus in low grade Huntington's disease using high resolution image analysis.
Sapp E; Ge P; Aizawa H; Bird E; Penney J; Young AB; Vonsattel JP; DiFiglia M
Neuroscience; 1995 Jan; 64(2):397-404. PubMed ID: 7535402
[TBL] [Abstract][Full Text] [Related]
43. Striatal changes in preproenkephalin mRNA levels in parkinsonian monkeys.
Asselin MC; Soghomonian JJ; Côté PY; Parent A
Neuroreport; 1994 Oct; 5(16):2137-40. PubMed ID: 7865763
[TBL] [Abstract][Full Text] [Related]
44. Glutamate receptor abnormalities in the YAC128 transgenic mouse model of Huntington's disease.
Benn CL; Slow EJ; Farrell LA; Graham R; Deng Y; Hayden MR; Cha JH
Neuroscience; 2007 Jun; 147(2):354-72. PubMed ID: 17544587
[TBL] [Abstract][Full Text] [Related]
45. Preferential loss of striato-external pallidal projection neurons in presymptomatic Huntington's disease.
Albin RL; Reiner A; Anderson KD; Dure LS; Handelin B; Balfour R; Whetsell WO; Penney JB; Young AB
Ann Neurol; 1992 Apr; 31(4):425-30. PubMed ID: 1375014
[TBL] [Abstract][Full Text] [Related]
46. Huntington's disease: changes in tachykinin content in postmortem brains.
Arai H; Emson PC; Carrasco LH
Ann Neurol; 1987 Nov; 22(5):587-94. PubMed ID: 2447825
[TBL] [Abstract][Full Text] [Related]
47. Thalamo-striatal deafferentation affects preproenkephalin but not preprotachykinin gene expression in the rat striatum.
Salin P; Kachidian P
Brain Res Mol Brain Res; 1998 Jun; 57(2):257-65. PubMed ID: 9675424
[TBL] [Abstract][Full Text] [Related]
48. Huntington's disease gene: regional and cellular expression in brain of normal and affected individuals.
Landwehrmeyer GB; McNeil SM; Dure LS; Ge P; Aizawa H; Huang Q; Ambrose CM; Duyao MP; Bird ED; Bonilla E
Ann Neurol; 1995 Feb; 37(2):218-30. PubMed ID: 7847863
[TBL] [Abstract][Full Text] [Related]
49. A genetic study of red cell osmotic fragility in Huntington's disease.
McCormack MK; Lazzarini A; Toke D; Lepore F
Am J Med Genet; 1984 May; 18(1):5-11. PubMed ID: 6234801
[TBL] [Abstract][Full Text] [Related]
50. Striatopallidal neurons are selectively protected by neurturin in an excitotoxic model of Huntington's disease.
Marco S; Pérez-Navarro E; Tolosa E; Arenas E; Alberch J
J Neurobiol; 2002 Mar; 50(4):323-32. PubMed ID: 11891666
[TBL] [Abstract][Full Text] [Related]
51. Gene expression in striatal grafts--I. Cellular localization of neurotransmitter mRNAs.
Sirinathsinghji DJ; Morris BJ; Wisden W; Northrop A; Hunt SP; Dunnett SB
Neuroscience; 1990; 34(3):675-86. PubMed ID: 1972268
[TBL] [Abstract][Full Text] [Related]
52. Differential loss of striatal projection systems in Huntington's disease: a quantitative immunohistochemical study.
Deng YP; Albin RL; Penney JB; Young AB; Anderson KD; Reiner A
J Chem Neuroanat; 2004 Jun; 27(3):143-64. PubMed ID: 15183201
[TBL] [Abstract][Full Text] [Related]
53. Met-enkephalin and preproenkephalin mRNA changes in the striatum of the nicotine abstinence mouse.
Isola R; Zhang H; Duchemin AM; Tejwani GA; Neff NH; Hadjiconstantinou M
Neurosci Lett; 2002 May; 325(1):67-71. PubMed ID: 12023068
[TBL] [Abstract][Full Text] [Related]
54. Ontogeny of preproenkephalin mRNA expression in the rat retina.
Isayama T; McLaughlin PJ; Zagon IS
Vis Neurosci; 1996; 13(4):695-704. PubMed ID: 8870226
[TBL] [Abstract][Full Text] [Related]
55. Widespread heterogeneous neuronal loss across the cerebral cortex in Huntington's disease.
Nana AL; Kim EH; Thu DC; Oorschot DE; Tippett LJ; Hogg VM; Synek BJ; Roxburgh R; Waldvogel HJ; Faull RL
J Huntingtons Dis; 2014; 3(1):45-64. PubMed ID: 25062764
[TBL] [Abstract][Full Text] [Related]
56. Population characteristics of preproenkephalin mRNA-containing neurons in the globus pallidus of the rat.
Hoover BR; Marshall JF
Neurosci Lett; 1999 Apr; 265(3):199-202. PubMed ID: 10327165
[TBL] [Abstract][Full Text] [Related]
57. Changes in preproenkephalin messenger RNA level in the rat ventromedial hypothalamus during the estrous cycle.
Funabashi T; Brooks PJ; Kleopoulos SP; Grandison L; Mobbs CV; Pfaff DW
Brain Res Mol Brain Res; 1995 Jan; 28(1):129-34. PubMed ID: 7707866
[TBL] [Abstract][Full Text] [Related]
58. Acute and persistent suppression of preproenkephalin mRNA expression in the striatum following developmental hypoxic-ischemic injury.
Burke RE; Franklin SO; Inturrisi CE
J Neurochem; 1994 May; 62(5):1878-86. PubMed ID: 8158136
[TBL] [Abstract][Full Text] [Related]
59. [Huntington disease: 7 cases with relatively preserved neostriatal islets].
Vonsattel JP; Myers RH; Bird ED; Ge P; Richardson EP
Rev Neurol (Paris); 1992; 148(2):107-16. PubMed ID: 1534925
[TBL] [Abstract][Full Text] [Related]
60. Preproenkephalin gene expression in the rat spinal cord after noxious stimuli.
Noguchi K; Morita Y; Kiyama H; Sato M; Ono K; Tohyama M
Brain Res Mol Brain Res; 1989 May; 5(3):227-34. PubMed ID: 2725196
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
